APA (7th ed.) Citation

T, S., N, S., M, K., M, T., M, Y., Y, O., . . . N, N. (2026). Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE. NPJ breast cancer. https://doi.org/10.1038/s41523-026-00997-y

Chicago Style (17th ed.) Citation

T, Shimoi, et al. "Prospective Observational Study of Atezolizumab Plus Nab-paclitaxel in Patients with Metastatic Triple-negative Breast Cancer: JBCRG-C08/ATTRIBUTE." NPJ Breast Cancer 2026. https://doi.org/10.1038/s41523-026-00997-y.

MLA (9th ed.) Citation

T, Shimoi, et al. "Prospective Observational Study of Atezolizumab Plus Nab-paclitaxel in Patients with Metastatic Triple-negative Breast Cancer: JBCRG-C08/ATTRIBUTE." NPJ Breast Cancer, 2026, https://doi.org/10.1038/s41523-026-00997-y.